Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In vitro, AGS-003 plus Nexavar sorafenib blocked T cell expansion,
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury